Abnormal changes in metabolites caused by m 6 A methylation modification: The leading factors that induce the formation of immunosuppressive tumor microenvironment and their promising potential for clinical application
N6-methyladenosine (m A) RNA methylation modifications have been widely implicated in the metabolic reprogramming of various cell types within the tumor microenvironment (TME) and are essential for meeting the demands of cellular growth and maintaining tissue homeostasis, enabling cells to adapt to...
Gespeichert in:
Veröffentlicht in: | Journal of advanced research 2024-04 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | Journal of advanced research |
container_volume | |
creator | Zhao, Liang Guo, Junchen Xu, Shasha Duan, Meiqi Liu, Baiming Zhao, He Wang, Yihan Liu, Haiyang Yang, Zhi Yuan, Hexue Jiang, Xiaodi Jiang, Xiaofeng |
description | N6-methyladenosine (m
A) RNA methylation modifications have been widely implicated in the metabolic reprogramming of various cell types within the tumor microenvironment (TME) and are essential for meeting the demands of cellular growth and maintaining tissue homeostasis, enabling cells to adapt to the specific conditions of the TME. An increasing number of research studies have focused on the role of m
A modifications in glucose, amino acid and lipid metabolism, revealing their capacity to induce aberrant changes in metabolite levels. These changes may in turn trigger oncogenic signaling pathways, leading to substantial alterations within the TME. Notably, certain metabolites, including lactate, succinate, fumarate, 2-hydroxyglutarate (2-HG), glutamate, glutamine, methionine, S-adenosylmethionine, fatty acids and cholesterol, exhibit pronounced deviations from normal levels. These deviations not only foster tumorigenesis, proliferation and angiogenesis but also give rise to an immunosuppressive TME, thereby facilitating immune evasion by the tumor.
The primary objective of this review is to comprehensively discuss the regulatory role of m
A modifications in the aforementioned metabolites and their potential impact on the development of an immunosuppressive TME through metabolic alterations.
This review aims to elaborate on the intricate networks governed by the m
A-metabolite-TME axis and underscores its pivotal role in tumor progression. Furthermore, we delve into the potential implications of the m
A-metabolite-TME axis for the development of novel and targeted therapeutic strategies in cancer research. |
format | Article |
fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_38677545</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>38677545</sourcerecordid><originalsourceid>FETCH-pubmed_primary_386775453</originalsourceid><addsrcrecordid>eNqFUFlqAzEMNYXShDZXKLpAYJYsk_6F0tID5D94bE1GxbaMl8BctaepJ6Tf1Y8k3qKHHsSyqQ7Vum6azUKsYvyuSrVdd6jrJ7Fou91-v91sl-Ln2DsOVhpQo3QXjEAOLCbZs6FUViVzRA39BBZ2cJyxcTIyERceaxpI3ZY3OI0IBqUmd4FBqsQhQhplKo46KywzwjDfuml5ALI2O47Z-4Ax0rVQsuUAllRgdFcK7Cy6BNLpWU0BfGBLcb7gORWISvDiCcqQK0EMSO_NPdGLeBykibi692fx-vlxev9a-9xb1GcfyMownf-e0f5L-AWdwHI3</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Abnormal changes in metabolites caused by m 6 A methylation modification: The leading factors that induce the formation of immunosuppressive tumor microenvironment and their promising potential for clinical application</title><source>DOAJ Directory of Open Access Journals</source><source>Access via ScienceDirect (Elsevier)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Zhao, Liang ; Guo, Junchen ; Xu, Shasha ; Duan, Meiqi ; Liu, Baiming ; Zhao, He ; Wang, Yihan ; Liu, Haiyang ; Yang, Zhi ; Yuan, Hexue ; Jiang, Xiaodi ; Jiang, Xiaofeng</creator><creatorcontrib>Zhao, Liang ; Guo, Junchen ; Xu, Shasha ; Duan, Meiqi ; Liu, Baiming ; Zhao, He ; Wang, Yihan ; Liu, Haiyang ; Yang, Zhi ; Yuan, Hexue ; Jiang, Xiaodi ; Jiang, Xiaofeng</creatorcontrib><description>N6-methyladenosine (m
A) RNA methylation modifications have been widely implicated in the metabolic reprogramming of various cell types within the tumor microenvironment (TME) and are essential for meeting the demands of cellular growth and maintaining tissue homeostasis, enabling cells to adapt to the specific conditions of the TME. An increasing number of research studies have focused on the role of m
A modifications in glucose, amino acid and lipid metabolism, revealing their capacity to induce aberrant changes in metabolite levels. These changes may in turn trigger oncogenic signaling pathways, leading to substantial alterations within the TME. Notably, certain metabolites, including lactate, succinate, fumarate, 2-hydroxyglutarate (2-HG), glutamate, glutamine, methionine, S-adenosylmethionine, fatty acids and cholesterol, exhibit pronounced deviations from normal levels. These deviations not only foster tumorigenesis, proliferation and angiogenesis but also give rise to an immunosuppressive TME, thereby facilitating immune evasion by the tumor.
The primary objective of this review is to comprehensively discuss the regulatory role of m
A modifications in the aforementioned metabolites and their potential impact on the development of an immunosuppressive TME through metabolic alterations.
This review aims to elaborate on the intricate networks governed by the m
A-metabolite-TME axis and underscores its pivotal role in tumor progression. Furthermore, we delve into the potential implications of the m
A-metabolite-TME axis for the development of novel and targeted therapeutic strategies in cancer research.</description><identifier>EISSN: 2090-1224</identifier><identifier>PMID: 38677545</identifier><language>eng</language><publisher>Egypt</publisher><ispartof>Journal of advanced research, 2024-04</ispartof><rights>Copyright © 2024. Production and hosting by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38677545$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhao, Liang</creatorcontrib><creatorcontrib>Guo, Junchen</creatorcontrib><creatorcontrib>Xu, Shasha</creatorcontrib><creatorcontrib>Duan, Meiqi</creatorcontrib><creatorcontrib>Liu, Baiming</creatorcontrib><creatorcontrib>Zhao, He</creatorcontrib><creatorcontrib>Wang, Yihan</creatorcontrib><creatorcontrib>Liu, Haiyang</creatorcontrib><creatorcontrib>Yang, Zhi</creatorcontrib><creatorcontrib>Yuan, Hexue</creatorcontrib><creatorcontrib>Jiang, Xiaodi</creatorcontrib><creatorcontrib>Jiang, Xiaofeng</creatorcontrib><title>Abnormal changes in metabolites caused by m 6 A methylation modification: The leading factors that induce the formation of immunosuppressive tumor microenvironment and their promising potential for clinical application</title><title>Journal of advanced research</title><addtitle>J Adv Res</addtitle><description>N6-methyladenosine (m
A) RNA methylation modifications have been widely implicated in the metabolic reprogramming of various cell types within the tumor microenvironment (TME) and are essential for meeting the demands of cellular growth and maintaining tissue homeostasis, enabling cells to adapt to the specific conditions of the TME. An increasing number of research studies have focused on the role of m
A modifications in glucose, amino acid and lipid metabolism, revealing their capacity to induce aberrant changes in metabolite levels. These changes may in turn trigger oncogenic signaling pathways, leading to substantial alterations within the TME. Notably, certain metabolites, including lactate, succinate, fumarate, 2-hydroxyglutarate (2-HG), glutamate, glutamine, methionine, S-adenosylmethionine, fatty acids and cholesterol, exhibit pronounced deviations from normal levels. These deviations not only foster tumorigenesis, proliferation and angiogenesis but also give rise to an immunosuppressive TME, thereby facilitating immune evasion by the tumor.
The primary objective of this review is to comprehensively discuss the regulatory role of m
A modifications in the aforementioned metabolites and their potential impact on the development of an immunosuppressive TME through metabolic alterations.
This review aims to elaborate on the intricate networks governed by the m
A-metabolite-TME axis and underscores its pivotal role in tumor progression. Furthermore, we delve into the potential implications of the m
A-metabolite-TME axis for the development of novel and targeted therapeutic strategies in cancer research.</description><issn>2090-1224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqFUFlqAzEMNYXShDZXKLpAYJYsk_6F0tID5D94bE1GxbaMl8BctaepJ6Tf1Y8k3qKHHsSyqQ7Vum6azUKsYvyuSrVdd6jrJ7Fou91-v91sl-Ln2DsOVhpQo3QXjEAOLCbZs6FUViVzRA39BBZ2cJyxcTIyERceaxpI3ZY3OI0IBqUmd4FBqsQhQhplKo46KywzwjDfuml5ALI2O47Z-4Ax0rVQsuUAllRgdFcK7Cy6BNLpWU0BfGBLcb7gORWISvDiCcqQK0EMSO_NPdGLeBykibi692fx-vlxev9a-9xb1GcfyMownf-e0f5L-AWdwHI3</recordid><startdate>20240425</startdate><enddate>20240425</enddate><creator>Zhao, Liang</creator><creator>Guo, Junchen</creator><creator>Xu, Shasha</creator><creator>Duan, Meiqi</creator><creator>Liu, Baiming</creator><creator>Zhao, He</creator><creator>Wang, Yihan</creator><creator>Liu, Haiyang</creator><creator>Yang, Zhi</creator><creator>Yuan, Hexue</creator><creator>Jiang, Xiaodi</creator><creator>Jiang, Xiaofeng</creator><scope>NPM</scope></search><sort><creationdate>20240425</creationdate><title>Abnormal changes in metabolites caused by m 6 A methylation modification: The leading factors that induce the formation of immunosuppressive tumor microenvironment and their promising potential for clinical application</title><author>Zhao, Liang ; Guo, Junchen ; Xu, Shasha ; Duan, Meiqi ; Liu, Baiming ; Zhao, He ; Wang, Yihan ; Liu, Haiyang ; Yang, Zhi ; Yuan, Hexue ; Jiang, Xiaodi ; Jiang, Xiaofeng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_386775453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhao, Liang</creatorcontrib><creatorcontrib>Guo, Junchen</creatorcontrib><creatorcontrib>Xu, Shasha</creatorcontrib><creatorcontrib>Duan, Meiqi</creatorcontrib><creatorcontrib>Liu, Baiming</creatorcontrib><creatorcontrib>Zhao, He</creatorcontrib><creatorcontrib>Wang, Yihan</creatorcontrib><creatorcontrib>Liu, Haiyang</creatorcontrib><creatorcontrib>Yang, Zhi</creatorcontrib><creatorcontrib>Yuan, Hexue</creatorcontrib><creatorcontrib>Jiang, Xiaodi</creatorcontrib><creatorcontrib>Jiang, Xiaofeng</creatorcontrib><collection>PubMed</collection><jtitle>Journal of advanced research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhao, Liang</au><au>Guo, Junchen</au><au>Xu, Shasha</au><au>Duan, Meiqi</au><au>Liu, Baiming</au><au>Zhao, He</au><au>Wang, Yihan</au><au>Liu, Haiyang</au><au>Yang, Zhi</au><au>Yuan, Hexue</au><au>Jiang, Xiaodi</au><au>Jiang, Xiaofeng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Abnormal changes in metabolites caused by m 6 A methylation modification: The leading factors that induce the formation of immunosuppressive tumor microenvironment and their promising potential for clinical application</atitle><jtitle>Journal of advanced research</jtitle><addtitle>J Adv Res</addtitle><date>2024-04-25</date><risdate>2024</risdate><eissn>2090-1224</eissn><abstract>N6-methyladenosine (m
A) RNA methylation modifications have been widely implicated in the metabolic reprogramming of various cell types within the tumor microenvironment (TME) and are essential for meeting the demands of cellular growth and maintaining tissue homeostasis, enabling cells to adapt to the specific conditions of the TME. An increasing number of research studies have focused on the role of m
A modifications in glucose, amino acid and lipid metabolism, revealing their capacity to induce aberrant changes in metabolite levels. These changes may in turn trigger oncogenic signaling pathways, leading to substantial alterations within the TME. Notably, certain metabolites, including lactate, succinate, fumarate, 2-hydroxyglutarate (2-HG), glutamate, glutamine, methionine, S-adenosylmethionine, fatty acids and cholesterol, exhibit pronounced deviations from normal levels. These deviations not only foster tumorigenesis, proliferation and angiogenesis but also give rise to an immunosuppressive TME, thereby facilitating immune evasion by the tumor.
The primary objective of this review is to comprehensively discuss the regulatory role of m
A modifications in the aforementioned metabolites and their potential impact on the development of an immunosuppressive TME through metabolic alterations.
This review aims to elaborate on the intricate networks governed by the m
A-metabolite-TME axis and underscores its pivotal role in tumor progression. Furthermore, we delve into the potential implications of the m
A-metabolite-TME axis for the development of novel and targeted therapeutic strategies in cancer research.</abstract><cop>Egypt</cop><pmid>38677545</pmid></addata></record> |
fulltext | fulltext |
identifier | EISSN: 2090-1224 |
ispartof | Journal of advanced research, 2024-04 |
issn | 2090-1224 |
language | eng |
recordid | cdi_pubmed_primary_38677545 |
source | DOAJ Directory of Open Access Journals; Access via ScienceDirect (Elsevier); EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry |
title | Abnormal changes in metabolites caused by m 6 A methylation modification: The leading factors that induce the formation of immunosuppressive tumor microenvironment and their promising potential for clinical application |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T15%3A09%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Abnormal%20changes%20in%20metabolites%20caused%20by%20m%206%20A%20methylation%20modification:%20The%20leading%20factors%20that%20induce%20the%20formation%20of%20immunosuppressive%20tumor%20microenvironment%20and%20their%20promising%20potential%20for%20clinical%20application&rft.jtitle=Journal%20of%20advanced%20research&rft.au=Zhao,%20Liang&rft.date=2024-04-25&rft.eissn=2090-1224&rft_id=info:doi/&rft_dat=%3Cpubmed%3E38677545%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/38677545&rfr_iscdi=true |